Frankincense of Boswellia sacra: Traditional and modern applied uses, pharmacological activities, and clinical trials

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389030%3A_____%2F23%3A00575939" target="_blank" >RIV/61389030:_____/23:00575939 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61989592:15310/23:73623017

Výsledek na webu

<a href="https://doi.org/10.1016/j.indcrop.2023.117106" target="_blank" >https://doi.org/10.1016/j.indcrop.2023.117106</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.indcrop.2023.117106" target="_blank" >10.1016/j.indcrop.2023.117106</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Frankincense of Boswellia sacra: Traditional and modern applied uses, pharmacological activities, and clinical trials

Popis výsledku v původním jazyce

Since Boswellia sacra (Burseraceae) was studied in the 19th century, it has been known for its economic and cultural values. It is cultivated mainly in the southwest regions of Oman and some regions of Yemen, and is a natural source of frankincense, “Luban” in Arabic, around the world. Frankincense, the aromatic resin of B. sacra, is used widely both for traditional purposes and for the treatment of various ailments, e.g., dental infections, tumors, dysentery, vomiting, and fevers. Recently, many reports provided evidence for the potential biological activities of B. sacra, its synonym Boswellia carteri, and their constituent chemical compounds. These activities include cytotoxic, anti-inflammatory, antimicrobial, anti-diabetes, immunomodulatory, and anticoagulant effects. B. sacra was also tested for effects against gastric, hepatic, neurological, and skin disorders in vitro and in vivo. Clinical trials revealed good effects against carcinomas and gliomas, as well as against bladder and brain tumors. Its uses as a plant-based agent in nanotechnology displayed promising results. More efforts should be directed to further investigate these safe, plant-based bio-preservatives, and best practices should be outlined to protect these trees from extinction.

Název v anglickém jazyce

Frankincense of Boswellia sacra: Traditional and modern applied uses, pharmacological activities, and clinical trials

Popis výsledku anglicky

Since Boswellia sacra (Burseraceae) was studied in the 19th century, it has been known for its economic and cultural values. It is cultivated mainly in the southwest regions of Oman and some regions of Yemen, and is a natural source of frankincense, “Luban” in Arabic, around the world. Frankincense, the aromatic resin of B. sacra, is used widely both for traditional purposes and for the treatment of various ailments, e.g., dental infections, tumors, dysentery, vomiting, and fevers. Recently, many reports provided evidence for the potential biological activities of B. sacra, its synonym Boswellia carteri, and their constituent chemical compounds. These activities include cytotoxic, anti-inflammatory, antimicrobial, anti-diabetes, immunomodulatory, and anticoagulant effects. B. sacra was also tested for effects against gastric, hepatic, neurological, and skin disorders in vitro and in vivo. Clinical trials revealed good effects against carcinomas and gliomas, as well as against bladder and brain tumors. Its uses as a plant-based agent in nanotechnology displayed promising results. More efforts should be directed to further investigate these safe, plant-based bio-preservatives, and best practices should be outlined to protect these trees from extinction.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30205 - Hematology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Industrial Crops and Products

ISSN

0926-6690

e-ISSN

1872-633X

Svazek periodika

203

Číslo periodika v rámci svazku

NOV 1

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

18

Strana od-do

117106

Kód UT WoS článku

001048888700001

EID výsledku v databázi Scopus

2-s2.0-85164662609